On the recordMarch 2, 2020
I do, again, want to reiterate my concerns about lifting regulatory requirements on qualifications required to prescribe these medications for MAT and I think that they are there for a reason.
Source
congress.govLarry Bucshon: “I do, again, want to reiterate my concerns about lifting regulatory requirements on qualifications required to prescribe…”
Editor's note · Context
Bucshon expresses concerns about easing regulations on medication-assisted treatment prescriptions.
Share
More from Larry Bucshon
May 25, 2023
I support Mr. Miller's amendment, which would require the Attorney General to issue interim final rules to implement this act 6 months after the date of enactment. Fentanyl-related substances will still be permanently placed in schedule I…
May 14, 2024
I have one additional speaker. Mr. Speaker, I yield 1 minute to the gentleman from Georgia (Mr. Carter).
Sep 23, 2024
In closing, I encourage everyone to vote ``yes'' on this bill, and I yield back the balance of my time. The SPEAKER pro tempore (Mr. Lopez). The question is on the motion offered by the gentleman from Indiana (Mr. Bucshon) that the House…
Dec 16, 2024
In closing, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time. The SPEAKER pro tempore (Mr. Valadao). The question is on the motion offered by the gentleman from Indiana (Mr. Bucshon) that the House suspend…
Other voices in this conversation
